Aurora Cannabis (ACB) Total Debt Growth (3y) (2021 - 2026)
Aurora Cannabis (ACB) Total Debt Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 15.43% |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -7.08% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 11.33% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -3.67% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -10.43% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -13.72% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 92.83% |
| 10 | Aurora Cannabis | 235.30 Mn | 162.99 Mn | 25.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -79.58% |
| Dec 31, 2025 | -34.47% |
| Sep 30, 2025 | -34.52% |
| Jun 30, 2025 | 46.17% |
| Mar 31, 2025 | 461.55% |
| Dec 31, 2024 | 632.69% |
| Sep 30, 2024 | 537.75% |
| Jun 30, 2024 | 540.35% |
| Mar 31, 2024 | 468.31% |
| Dec 31, 2023 | 691.89% |
| Sep 30, 2023 | 725.73% |
| Jun 30, 2023 | 128.42% |
| Mar 31, 2023 | -54.61% |
| Dec 31, 2022 | -52.52% |
| Sep 30, 2022 | 21.41% |
| Jun 30, 2022 | -52.42% |
| Mar 31, 2022 | -77.15% |
| Dec 31, 2021 | -68.23% |
| Sep 30, 2021 | -65.70% |
| Jun 30, 2021 | -41.07% |